pamidronate disodium Vials, injection 90 mg, 30 mg

This pharmaceutical company, founded in 2007 and based in the US, specializes in developing, marketing, and distributing affordable multi-source pharmaceutical products. They have a growing portfolio of medications across various therapy areas. While specific details about their product lines are not provided, they mention focusing on high quality and efficacy, suggesting a commitment to meeting rigorous standards. The company's distribution likely spans North America and potentially the EU given their mention of "expanding into new markets." They emphasize affordability, potentially targeting a wider patient base compared to companies solely focused on niche therapies or expensive specialty medications.